What’s New in Healthcare: Fast-Track Approval for Ketamine-Based Treatment

Developments like NRX-100 are a reminder that innovation in mental health happens quickly, and billing systems need to keep pace. At TNT, we help practices stay prepared for changes like these, so providers can focus on patient care while we handle the claims, codes, and compliance.

Key Takeaways

A lot of billing companies stop at the basics: submit claims, post payments, and pass the hard stuff – denials, collections, aging AR – back to your staff.

At TNT, we manage the entire revenue cycle from charge entry to final payment. We track every dollar, appeal denials, and only loop you in when clinical input is needed. Our goal is to take the weight off your team completely.

That could mean:
  • New Codes & Coverage Decisions – Payers typically release coding and reimbursement guidance for new therapies. Being ready helps avoid missed revenue.
  • Documentation Requirements – Treatments tied to mental health and high-cost drugs often face stricter documentation and authorization standards.
  • Patient Access – Fast Track designation aims to speed patient access, but providers must ensure billing doesn’t become a barrier when coverage details roll out.

The Latest: Understanding Fast Track

Just this past month, the FDA granted Fast Track designation to NRX-100 – the latest oral ketamine-based treatment being developed for patients with suicidal ideation. Here’s everything providers need to know about this groundbreaking development and how this may impact billing.